A Pyridazine-Based Fluorescent Probe Targeting Aβ Plaques in Alzheimer’s Disease

Accumulation of β-amyloid (Aβ) plaques comprising Aβ40 and Aβ42 in the brain is the most significant factor in the pathogenesis of Alzheimer’s disease (AD). Thus, the detection of Aβ plaques has increasingly attracted interest in the context of AD diagnosis. In the present study, a fluorescent pyrid...

Full description

Saved in:
Bibliographic Details
Main Authors: Yong Dae Park, Jeum-Jong Kim, Sungbeom Lee, Chul-Hong Park, Hyoung-Woo Bai, Seung Sik Lee
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Analytical Methods in Chemistry
Online Access:http://dx.doi.org/10.1155/2018/1651989
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849305438631231488
author Yong Dae Park
Jeum-Jong Kim
Sungbeom Lee
Chul-Hong Park
Hyoung-Woo Bai
Seung Sik Lee
author_facet Yong Dae Park
Jeum-Jong Kim
Sungbeom Lee
Chul-Hong Park
Hyoung-Woo Bai
Seung Sik Lee
author_sort Yong Dae Park
collection DOAJ
description Accumulation of β-amyloid (Aβ) plaques comprising Aβ40 and Aβ42 in the brain is the most significant factor in the pathogenesis of Alzheimer’s disease (AD). Thus, the detection of Aβ plaques has increasingly attracted interest in the context of AD diagnosis. In the present study, a fluorescent pyridazine-based dye that can detect and image Aβ plaques was designed and synthesized, and its optical properties in the presence of Aβ aggregates were evaluated. An approximately 34-fold increase in emission intensity was exhibited by the fluorescent probe after binding with Aβ aggregates, for which it showed high affinity (KD = 0.35 µM). Moreover, the reasonable hydrophobic properties of the probe (log P = 2.94) allow it to penetrate the blood brain barrier (BBB). In addition, the pyridazine-based probe was used in the histological costaining of transgenic mouse (APP/PS1) brain sections to validate the selective binding of the probe to Aβ plaques. The results suggest that the pyridazine-based compound has the potential to serve as a fluorescent probe for the diagnosis of AD.
format Article
id doaj-art-080622b182974254907ea5df15f57595
institution Kabale University
issn 2090-8865
2090-8873
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Analytical Methods in Chemistry
spelling doaj-art-080622b182974254907ea5df15f575952025-08-20T03:55:27ZengWileyJournal of Analytical Methods in Chemistry2090-88652090-88732018-01-01201810.1155/2018/16519891651989A Pyridazine-Based Fluorescent Probe Targeting Aβ Plaques in Alzheimer’s DiseaseYong Dae Park0Jeum-Jong Kim1Sungbeom Lee2Chul-Hong Park3Hyoung-Woo Bai4Seung Sik Lee5Research Division for Biotechnology, Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup 580-185, Republic of KoreaTechnology Innovation Support Team, Korea Research Institute of Chemical Technology (KRICT), Deajeon 305-600, Republic of KoreaResearch Division for Biotechnology, Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup 580-185, Republic of KoreaResearch Division for Biotechnology, Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup 580-185, Republic of KoreaResearch Division for Biotechnology, Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup 580-185, Republic of KoreaResearch Division for Biotechnology, Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup 580-185, Republic of KoreaAccumulation of β-amyloid (Aβ) plaques comprising Aβ40 and Aβ42 in the brain is the most significant factor in the pathogenesis of Alzheimer’s disease (AD). Thus, the detection of Aβ plaques has increasingly attracted interest in the context of AD diagnosis. In the present study, a fluorescent pyridazine-based dye that can detect and image Aβ plaques was designed and synthesized, and its optical properties in the presence of Aβ aggregates were evaluated. An approximately 34-fold increase in emission intensity was exhibited by the fluorescent probe after binding with Aβ aggregates, for which it showed high affinity (KD = 0.35 µM). Moreover, the reasonable hydrophobic properties of the probe (log P = 2.94) allow it to penetrate the blood brain barrier (BBB). In addition, the pyridazine-based probe was used in the histological costaining of transgenic mouse (APP/PS1) brain sections to validate the selective binding of the probe to Aβ plaques. The results suggest that the pyridazine-based compound has the potential to serve as a fluorescent probe for the diagnosis of AD.http://dx.doi.org/10.1155/2018/1651989
spellingShingle Yong Dae Park
Jeum-Jong Kim
Sungbeom Lee
Chul-Hong Park
Hyoung-Woo Bai
Seung Sik Lee
A Pyridazine-Based Fluorescent Probe Targeting Aβ Plaques in Alzheimer’s Disease
Journal of Analytical Methods in Chemistry
title A Pyridazine-Based Fluorescent Probe Targeting Aβ Plaques in Alzheimer’s Disease
title_full A Pyridazine-Based Fluorescent Probe Targeting Aβ Plaques in Alzheimer’s Disease
title_fullStr A Pyridazine-Based Fluorescent Probe Targeting Aβ Plaques in Alzheimer’s Disease
title_full_unstemmed A Pyridazine-Based Fluorescent Probe Targeting Aβ Plaques in Alzheimer’s Disease
title_short A Pyridazine-Based Fluorescent Probe Targeting Aβ Plaques in Alzheimer’s Disease
title_sort pyridazine based fluorescent probe targeting aβ plaques in alzheimer s disease
url http://dx.doi.org/10.1155/2018/1651989
work_keys_str_mv AT yongdaepark apyridazinebasedfluorescentprobetargetingabplaquesinalzheimersdisease
AT jeumjongkim apyridazinebasedfluorescentprobetargetingabplaquesinalzheimersdisease
AT sungbeomlee apyridazinebasedfluorescentprobetargetingabplaquesinalzheimersdisease
AT chulhongpark apyridazinebasedfluorescentprobetargetingabplaquesinalzheimersdisease
AT hyoungwoobai apyridazinebasedfluorescentprobetargetingabplaquesinalzheimersdisease
AT seungsiklee apyridazinebasedfluorescentprobetargetingabplaquesinalzheimersdisease
AT yongdaepark pyridazinebasedfluorescentprobetargetingabplaquesinalzheimersdisease
AT jeumjongkim pyridazinebasedfluorescentprobetargetingabplaquesinalzheimersdisease
AT sungbeomlee pyridazinebasedfluorescentprobetargetingabplaquesinalzheimersdisease
AT chulhongpark pyridazinebasedfluorescentprobetargetingabplaquesinalzheimersdisease
AT hyoungwoobai pyridazinebasedfluorescentprobetargetingabplaquesinalzheimersdisease
AT seungsiklee pyridazinebasedfluorescentprobetargetingabplaquesinalzheimersdisease